Patents by Inventor Heiko Wiebusch

Heiko Wiebusch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for direct genetic analysis of target cells by using fluorescence probes
    Publication number: 20040091880
    Abstract: Methods for identifying a target cell and for genetic analysis are provided, which comprise in situ hybridizing of a target sequence in a target cell with a complementary labeled sequence and cell identification of the target cell by the aid of detecting hybridized sequence by flow cytometry. Methods for quantifying fetal mRNA within a maternal blood sample are also provided, which comprise amplifying fetal cell specific mRNA, synthesizing labeled sequences comprising a sequence being complementary or partly complementary to said amplified fetal cell specific mRNA, hybridizing said labeled sequence with said amplified fetal cell specific mRNA and detecting the hybridized labeled complementary sequence.
    Type: Application
    Filed: January 14, 2003
    Publication date: May 13, 2004
    Applicant: Praenadia GmbH
    Inventors: Heiko Wiebusch, Thomas Schmitt-John, Jurgen Weidner
  • Method for determining the prognosis of a patient with a neurological disease
    Publication number: 20020086290
    Abstract: The present invention provides a method for the determining the prognosis for a patient diagnosed with a neurological disease. The present invention also provides a method for the identification of human subjects for placement in clinical drug trials of drugs being tested for the treatment of neurological disease and for determining a patient's future disease risk.
    Type: Application
    Filed: April 13, 2000
    Publication date: July 4, 2002
    Inventors: Pierre Sevigny, Heiko Wiebusch, Keith Schappert
  • Methods for treating a neurological disease by determining BCHE genotype
    Patent number: 6291175
    Abstract: Disclosed herein is a method for treating a patient with a neurological disease by determining a patient's BCHE allele status.
    Type: Grant
    Filed: June 16, 1999
    Date of Patent: September 18, 2001
    Assignees: Variagenics, Inc., Institut Pasteur de Lille
    Inventors: Pierre Sévigny, Keith Schappert, Heiko Wiebusch, Philippe Amouye
  • Method for determining the prognosis of a patient with a neurological disease
    Patent number: 6251587
    Abstract: The present invention provides a method for the determining the prognosis for a patient diagnosed with a neurological disease. The present invention also provides a method for the identification of human subjects for placement in clinical drug trials of drugs being tested for the treatment of neurological disease and for determining a patient's future disease risk.
    Type: Grant
    Filed: December 16, 1997
    Date of Patent: June 26, 2001
    Assignee: Nova Molecular, Inc.
    Inventors: Pierre Sévigny, Heiko Wiebusch, Keith Schappert